Laidlaw served as Co-Manager on the $115,000,000 Offering for Affimed (AFMD)
Laidlaw Capital Markets is pleased to have Co-Managed Affimed’s $115,000,000 financing alongside Jefferies, SVB Leerink, and Credit Suisse.
Laidlaw served as Financial Advisor on the $20,000,000 Offering for Delcath Systems (DCTH)
Laidlaw Capital Markets is pleased to have served as a Financial Advisor to Delcath Systems on their $20,000,000 Follow-on Offering alongside Canaccord Genuity and Roth Capital
Laidlaw served as Lead Manager on the $147,500,000 Offering for Curis Inc (CRIS)
Laidlaw Capital Markets is pleased to have served as a Lead Manager on a $147,500,000 Follow-On Offering for Curis Inc (CRIS).
Laidlaw Wealth Management Acquires Naples Wealth Planning
Laidlaw Wealth Management is pleased to announce its acquisition and partnership with Naples Wealth Planning.
NEW YORK, NY, USA, October 19, 2020 /EINPresswire.com/ — Laidlaw Wealth Management is pleased to announce its acquisition and partnership with Naples Wealth Planning a well-recognized and respected RIA based in Naples, Florida.
The agreement will add four new offices in Naples, Tampa, Stuart, and Miami to Laidlaw’s existing Florida location in Boca Raton. In addition, this launches a new platform at Laidlaw to service and expand the 1099 model for advisors. This is an area Richard Calhoun, CEO of Laidlaw Wealth Management, knows well as he was instrumental in the growth of the Wells Fargo Advisors Financial Network from 245 offices to 642 offices, as Managing Director of Growth and Innovation.
Laidlaw Venture Partners portfolio company Amesite (AMST) announces pricing of Initial Public Offering of $15,000,000.
Laidlaw acted as the Sole Book-Runner, and previously completed the companies Series A and B rounds over the last two years.
Laidlaw Venture Partners Continues Strategic Growth with Addition of Mr. Anthony Zook to its Investment and Operations Committee
Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Mr. Anthony (‘Tony’) Zook to its newly formed Investment and Operations Committee. As a global industry leader, Zook brings years of strategic experience to Laidlaw Venture Partners and is expected to be instrumental in the further development and evolution of the LVP portfolio of companies.
Laidlaw served as Financial Advisor on the $173,000,000 Follow-On Offering for Arcturus Therapeutics (ARCT)
Laidlaw Capital Markets is pleased to have served as Financial Advisor to Arcturus Therapeutics on its $173,000,000 financing alongside Citigroup, Guggenheim Securities, and Barclays. Laidlaw has helped Arcturus in its efforts in 2020 raise approximately $250,000,000.
Laidlaw Venture Partners’ portfolio company Amesite CEO, Dr. Ann Marie Sastry, back on CNBC’s Squawk Box.
Ann Marie Sastry, founder and CEO of Amesite, joins “Squawk Box” to discuss how the Covid-19 pandemic is changing remote learnings for students and workers looking to continue their education.”
Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisors
Laidlaw Venture Partners, the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Jeff Conroy and George Serafin to its Board of Advisors. As industry leaders in Business Development and Regulatory/Compliance, both Conroy and Serafin bring years of strategic experience to Laidlaw Venture Partners and will be instrumental in the development and evolution of our innovative companies.
Laidlaw served as Co-Manager on the $50,000,000 Follow-On Offering for Soleno Therapeutics (SLNO) with Guggenheim Partners
Laidlaw is pleased to have Co-Managed a $50,000,000 deal for Soleno Therapeutics (SLNO) with Guggenheim Partners.